This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: Primary brain tumor patients are at increased risk for stroke from disease and treatment-specific mechanisms.
Methods: We conducted a retrospective review of patients with primary brain tumors diagnosed with MRI-confirmed ischemic stroke between 1996 and 2006. Data were collected including risk factors, diagnostic workup, and treatment for stroke. Modified Rankin Scale (MRS) scores at stroke diagnosis were determined, and stroke etiology was assigned using Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria for nonpostoperative strokes.
Results: Sixty-eight cases of confirmed ischemic stroke in 66 patients (56% men) were analyzed. The median age at time of stroke was 60 years. The distribution of stroke risk factors was comparable to the general stroke population. The most common brain tumors were gliomas, 60%; meningiomas, 25%; and primary CNS lymphoma, 6%. Stroke was the initial clinical diagnosis in only 43% of cases. The distribution of stroke etiology was operative complication, 49%; cardioembolic, 12%; small vessel lacune, 12%; large vessel, 6%; other, 15%; and undetermined, 7%. Seventeen patients (25%) had strokes related to delayed effects of radiation. The median latency from radiation to stroke diagnosis was 3.2 years. Therapy for secondary prevention of stroke was added in one-half of patients. Median survival from the time of stroke was 1.7 years and was correlated with MRS scores.
Conclusions: Treatment complications from surgery and radiotherapy account for the majority of ischemic strokes in patients with primary brain tumors. Stroke is often a missed diagnosis that can contribute additional neurologic disability in an already susceptible patient population.
Glossary
- ADC=
- apparent diffusion coefficient;
- CAD=
- coronary artery disease;
- DVT=
- deep venous thrombosis;
- DWI=
- diffusion-weighted imaging;
- MR=
- magnetic resonance;
- MRS=
- Modified Rankin Scale;
- MSKCC=
- Memorial Sloan-Kettering Cancer Center;
- NBTE=
- nonbacterial thrombotic endocarditis;
- OS=
- overall survival;
- PE=
- pulmonary embolus;
- PVD=
- peripheral vascular disease;
- RT=
- radiation therapy;
- TOAST=
- Trial of Org 10172 in Acute Stroke Treatment.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
